Literature DB >> 28822874

Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.

Ahmad Ziaee1, Ahmad B Albadarin2, Luis Padrela2, Alexandra Faucher2, Emmet O'Reilly2, Gavin Walker2.   

Abstract

A design of experiment (DoE) approach was used to investigate the critical formulation and processing parameters in spray drying ternary amorphous solid dispersions (ASDs) of ibuprofen. A range of 16 formulations of ibuprofen, HPMCP-HP55 and Kollidon VA 64 were spray dried. Statistical analysis revealed the interrelation of various spray drying process conditions and formulation factors, namely solution feed rate, inlet temperature, Active Pharmaceutical Ingredient (API)/excipients ratio and dichloromethane (DCM)/methanol (MeOH) ratio. Powder X-ray diffraction analysis (PXRD) showed that all the samples with the lowest API/excipient ratio (1:4) were amorphous, while others were crystalline. Moreover, differential scanning calorimetry (DSC) analysis was employed to investigate ASD formulation more in-depth. The glass transition temperatures (Tg) of all ASDs were in the range 70-79°C, while crystalline formulations displayed an endothermic peak of melting of crystalline ibuprofen in the range of 50-80°C. The high Tg of ASDs was an indication of highly stable ASD formulations as verified via PXRD at zero day and afterward at 1, 1.5, 3 and 6month intervals. The intermolecular interactions between ibuprofen molecule and excipients were studied by Fourier transform infrared spectroscopy (FTIR) and solid-state nuclear magnetic resonance (ssNMR) spectroscopy. FTIR and Carbon-13 ssNMR analysis indicated that hydrogen bond formation involving the carboxyl group in ibuprofen within the ASDs is likely. More importantly, the solubility of ibuprofen in ASD formulations is improved compared to pure ibuprofen. This was due to both the amorphous structure of ibuprofen and of the existence of amphiphilic excipient, Kollidon VA 64, in the formulation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amorphous solid dispersion; Design of experiments; Dissolution rate; Ibuprofen; Spray drying; Ternary formulations

Mesh:

Substances:

Year:  2017        PMID: 28822874     DOI: 10.1016/j.ejpb.2017.08.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  9 in total

1.  A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.

Authors:  S Focaroli; P T Mah; J E Hastedt; I Gitlin; S Oscarson; J V Fahy; A M Healy
Journal:  Int J Pharm       Date:  2019-03-05       Impact factor: 5.875

2.  Densifying Co-Precipitated Amorphous Dispersions to Achieve Improved Bulk Powder Properties.

Authors:  Derek S Frank; Ashish Punia; Mairead Fahy; Chad Dalton; Jasmine Rowe; Luke Schenck
Journal:  Pharm Res       Date:  2022-10-21       Impact factor: 4.580

3.  Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization.

Authors:  Yeo-Song Lee; Jae Guen Song; Sang Hoon Lee; Hyo-Kyung Han
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  A Novel Protocol Using Small-Scale Spray-Drying for the Efficient Screening of Solid Dispersions in Early Drug Development and Formulation, as a Straight Pathway from Screening to Manufacturing Stages.

Authors:  Aymeric Ousset; Rosanna Chirico; Florent Robin; Martin Alexander Schubert; Pascal Somville; Kalliopi Dodou
Journal:  Pharmaceuticals (Basel)       Date:  2018-08-27

5.  Applying Supercritical Fluid Technology to Prepare Ibuprofen Solid Dispersions with Improved Oral Bioavailability.

Authors:  Fei Han; Wei Zhang; Ying Wang; Ziyue Xi; Lu Chen; Sanming Li; Lu Xu
Journal:  Pharmaceutics       Date:  2019-02-03       Impact factor: 6.321

6.  How Does the Addition of Kollidon®VA64 Inhibit the Recrystallization and Improve Ezetimibe Dissolution from Amorphous Solid Dispersions?

Authors:  Joanna Szafraniec-Szczęsny; Agata Antosik-Rogóż; Mateusz Kurek; Karolina Gawlak; Anna Górska; Sebastian Peralta; Justyna Knapik-Kowalczuk; Daniel Kramarczyk; Marian Paluch; Renata Jachowicz
Journal:  Pharmaceutics       Date:  2021-01-23       Impact factor: 6.321

7.  Predicting process design spaces for spray drying amorphous solid dispersions.

Authors:  Stefanie Dohrn; Pranay Rawal; Christian Luebbert; Kristin Lehmkemper; Samuel O Kyeremateng; Matthias Degenhardt; Gabriele Sadowski
Journal:  Int J Pharm X       Date:  2021-02-25

8.  Formulation and In Vitro Characterization of a Vacuum-Dried Drug-Polymer Thin Film for Intranasal Application.

Authors:  Daisuke Inoue; Ayari Yamashita; Hideto To
Journal:  Polymers (Basel)       Date:  2022-07-21       Impact factor: 4.967

Review 9.  Insoluble Polymers in Solid Dispersions for Improving Bioavailability of Poorly Water-Soluble Drugs.

Authors:  Thao T D Tran; Phuong H L Tran
Journal:  Polymers (Basel)       Date:  2020-07-28       Impact factor: 4.329

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.